NEW YORK, May 7, 2012 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Alexza Pharmaceuticals Inc. ("Alexza Pharmaceuticals" or the "Company") (NasdaqGM: ALXA -News), concerning whether the company and certain of its officers and directors have violated federal securities laws.
On May 4, 2012, shares Alexza Pharmaceuticals fell 20% or 12 cents to close at 49 cents after the FDA denied approval citing manufacturing deficiencies that affected its decision on Adasuve which is a drug designed to rapidly treat agitation related to schizophrenia and bipolar disorder. Alexza Pharmaceuticals said the FDA won't approve the drug after citing manufacturing problems at a company plant in Mountain View, California.
If you are aware of any facts relating to this investigation, or purchased shares of Alexza Pharmaceuticals, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.Contact:Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Eitan Kimelman, 212-697-6484 email@example.com SOURCE Bronstein, Gewirtz & Grossman, LLC
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts